期刊文献+

养心氏对巨噬细胞极化及活化的调节 被引量:13

Regulation of Yangxinshi Tablets in the Macrophage Polarization and Activation
下载PDF
导出
摘要 目的以人单核细胞株THP-1细胞为基础,观察养心氏对THP-1源性巨噬细胞极化和活化的影响,为养心氏抗动脉粥样硬化机制提供理论依据。方法分别以不同浓度(10mg/L,25mg/L和50mg/L)的氧化型低密度脂蛋白(ox-LDL)刺激THP-1源性巨噬细胞24h,以空白为对照组,用ELISA法测定上清液中的单核细胞趋化蛋白-1(MCP-1)和巨噬细胞移动抑制因子(MIF)的浓度,用流式细胞术检测巨噬细胞表面CD16及CD68的表达。用不同浓度的养心氏(10mg/L,50mg/L和100mg/L)预处理THP-1源性巨噬细胞12h,再用50mg/L的ox-LDL刺激THP-1源性巨噬细胞24h,检测上清液中MIF、MCP-1的浓度以及CD16及CD68的表达情况。结果 ox-LDL能以剂量依赖的方式诱导THP-1源性巨噬细胞分泌MCP-1和MIF,其中50mg/L组表达最高,MCP-1(29.30±1.48)pg/mL,对照组为(5.71±1.94)pg/mL;MIF(18.67±0.15)ng/mL,对照组为(4.61±0.40)ng/mL(P<0.01)。ox-LDL能改变巨噬细胞表面抗原CD16、CD68的表达,50mg/L组能显著下调CD16、CD68的表达(CD16:26.9vs对照组29.8;CD68:22.3vs对照组25.2)。养心氏能够以剂量依赖的方式抑制ox-LDL所致的THP-1源性巨噬细胞分泌MCP-1和MIF,随着养心氏刺激浓度的增加,MCP-1和MIF的分泌减少。结论养心氏可能通过抑制巨噬细胞炎性活化,抑制巨噬细胞向促炎表型转化进而抑制动脉粥样硬化的形成和发展。 Objective To explore the anti atherosclerotic mechanism of Yangxinshi tablets(YXST),we stimulated THP 1 derived macrophages with YXST and observed its effects on macrophage polarity switch and activation.Methods Human monocytic cel line THP 1 were differentiated into macrophages by stimulated with 160 nmol/L phorbol 12 myristate 13 acetate (PMA)for 24 h.Then THP 1 derived macrophages were stimulated by different concentrations of oxidized low density lipoprotein (ox LDL)for 24 h, which were 10mg/L,25mg/L and 50mg/L,and blank was used as control.The secretion of monocyte chemotactic protein 1 (MCP 1) and macrophage migration inhibition factor (MIF)were detected by ELISA,and the membrane molecule CD16 and CD68 were tested by flow cytometry.THP 1 derived macrophages were pretreated with different concentrations of YXST (10 mg/L,50 mg/L and 100 mg/L)12 h.Then we stimulated these cel s by ox LDL (50 mg/L)for 24 h and detected the secretion of MIF,MCP 1 and the ex-pression of CD16 and CD68 again.Results The ox LDL up regulatet the secretion of MCP 1 and MIF as a dose dependent manner in THP 1 derived macrophages.With the increasing concentration of ox LDL,the secretion of MCP 1 and MIF increased, 50mg/L group reached their secretion peaks after 24h(MCP 1:29.30± 1.48 pg/mL vs.control 5.71± 1.94 pg/mL;MIF:18.67± 0.15 ng/mL vs.control 4.61± 0.40 ng/mL;P〈0.01).The expression of CD16 and CD68 were varied with different ox LDL concentrations.The mean fluorescence intensity of CD16 and CD68 was significantly reduced in 50mg/L group (CD16:26.9 vs.control 29.8;CD68:22.3 vs. control 25.2).YXST inhibited the expression of MCP 1 and MIF induced by ox LDL as a dose dependent manner.With the increas-ing concentration of Yangxinshi,the secretion of MCP 1 and MIF decreased.The 100mg/L group declined mostly(MCP 1:9.95± 2.09 pg/mL vs.control 33.30± 2.37 pg/mL;MIF:4.85± 0.12 ng/mL vs.control 18.65± 0.15 ng/mL;P〈0.01).Yangxinshi change the ex-pression of CD16 and CD68 reduced by ox LDL as a dose dependent manner,the mean fluorescence intensity of CD16 and CD68 was significantly up regulated in 100 mg/L group (CD16:96 vs.control 26.9;CD68:91.6 vs.control 22.3).Conclusion YXST may ex-ecute its anti atherosclerotic effect by inhibiting macrophage inflammatory activation and affecting macrophage polarity switch.
出处 《中西医结合心脑血管病杂志》 2016年第15期1722-1726,共5页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 动脉粥样硬化 巨噬细胞极化 养心氏 单核细胞趋化蛋白-1 巨噬细胞移动抑制因子 atherosclerosis macrophage polarization Yangxinshi tablets macrophage migration in-hibition factor
  • 相关文献

参考文献12

  • 1Fulya Ilhan,Sevgi Tas Kalkanli.Atherosclerosis and the role of immune cells[J].World Journal of Clinical Cases,2015,3(4):345-352. 被引量:10
  • 2De Paoli F,Staels B,Chinetti - Gbaguidi G.Macrophage pheno- types and their modulation in atherosclerosis [J].Circulation Journal,2014,78(8):1775-1781.
  • 3Yan ZQ,Hansson GK.Innate immunity,macrophage activation,and atherosclerosis [J].Immunological Reviews,2007,219:187-203.
  • 4Atsumi T,Nishihira J,Makita Z,et al.Enhancement of oxidised low - density lipoprotein uptake by macrophages in response to macrophage migration inhibitory factor [J].Cytokine,2000,12(10):1553-1556.
  • 5严冬,钱玉良,唐蜀华.养心氏对气虚血瘀型冠心病心绞痛患者ET、NO、CRP的影响[J].中西医结合心脑血管病杂志,2011,9(6):656-658. 被引量:21
  • 6Lin J,Kakkar V,Lu X.lmpact of MCP -1 in atherosclerosis [J].Current Pharmaceutical Design,2014,20(28):4580-4588.
  • 7MullerIU Muller KA,Schonleber H,ef al.Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response [J].PIoS One,2012,7(6):e38376.
  • 8Bouhlel MA^Derudas B,Rigamonti E,et al.PPAR gamma acti- vation primes human monocytes into alternative M2 macropha- ges with anti - inflammatory properties [J].Cell Metabolism,2007,6(2):137-143.
  • 9Sica A,Schioppa T,Mantovani A,et al.Tumour - associated macrophages are a distinct M2 polarised population promoting tumour progression:potential targets of anti - cancer therapy [J].European Journal of Cancer (Oxford,England:1990),2006,42(6):717-727.
  • 10Wahl SMtAIIen JB,Welch GR,et al.Transforming growth fac- tor -beta in synovial fluids modulates Fe gamma Rll (CD16) ex- pression on mononuclear phagocytes [J].Journal of Immunolo- gy,1992,148(2):485- 490.

二级参考文献8

共引文献29

同被引文献211

引证文献13

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部